Switzer TV

In this week’s Switzer Investing TV, Paul Rickard sits down with chartist and market analyst Mike Gable to break down the big ideas driving today’s bull market — from rare earths and uranium to the comeback stories in healthcare and banking.

They look at what’s powering the ASX200’s latest rally, whether the US market still has room to run, and which sectors could surprise next. Plus, Gable shares how he’s positioning in gold, why CSL might finally be turning the corner, and where he sees upside in Macquarie.

In this episode:

• The ASX200’s breakout — sustainable or overdone?

• Rare earths vs lithium: is history repeating?

• Uranium and gold: the commodities back in focus

• Has CSL bottomed, and what’s next for healthcare?

• The banks and Macquarie — are they about to run again?

If you’re looking for market insight that blends technical charts with fundamental reasoning, this is a must-watch for every Australian investor.

Hosted by Paul Rickard | Guest: Mike Gable, Managing Director, Fairmont Equities.

Switzer Investing TV | 20 Oct 2025: Are rare earths about to get the Lithium hosing? Plus: Can US shares run even higher, and will the ASX200 follow?

We break down the big ideas driving today’s bull market: from rare earths and uranium to the comeback stories in healthcare and banking.

More videos

Sold-off stocks that experts are buying!

Joining Peter Switzer on this week's show are Julia Lee, Jim Rogers, Christopher Joye, Adam Dawes and Paul Rickard.

Series: ,
The link between diabetes and cancer

In this week's episode, Dr Ross Walker looks at the links between diabetes and another disease: cancer.

Series: ,
Mad about Money

Join Peter Switzer and Paul Rickard for the latest episode of Mad about Money.

Series: ,
What stocks are the experts buying? Plus, should you gamble on Mesoblast?

Join Peter Switzer with guests; Julia Lee, Jun Bei Liu, Gemma Dale & ST Wong

Series: ,
The link between diabetes and Alzheimer's disease

In this week's episode, Dr Ross Walker looks at research that has shown a link between Type 2 diabetes and Alzheimer's.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
What stocks will head higher thanks to the budget & Julia Lee on Mesoblast!

Burman Invest's Julia Lee, Shaw and Partners' Adam Dawes, FNArena's Rudi Filapek-Vandyck and Switzer's Paul Rickard join Peter Switzer.

Series: ,
The link between diabetes and heart disease

Dr Ross Walker talks about the little-known connection between diabetes and cardiovascular disease.

Series: ,
Mad about Money Live

Peter Switzer and Paul Rickard share their views on the latest money and market news.

Series: ,
Experts tell you the stocks you should buy and the ones you should dump!

Julia Lee, Paul Rickard, Jun Bei Liu, Peter Switzer and Michael Gable share their analysis of some stock opportunities.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for a live look at the latest market and money news.

Series: ,
Our experts assess Brainchip, Nearmap, Treasury Wines and tech stocks

Peter Switzer speaks to Burman Invest CIO Julia Lee, Shaw and Partners Senior Investment Adviser Adam Dawes, Yellow Brick Road Chairman Mark Bouris, McPherson's CEO Laurie McAllister and Switzer Report co-founder Paul Rickard.

Series: ,
1 39 40 41 42 43 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram